WUXI BIOLOGICS Financials
| 1FW1 Stock | EUR 3.38 0.14 3.98% |
WUXI |
Understanding current and past WUXI BIOLOGICS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of WUXI BIOLOGICS's financial statements are interrelated, with each one affecting the others. For example, an increase in WUXI BIOLOGICS's assets may result in an increase in income on the income statement.
WUXI BIOLOGICS Stock Summary
WUXI BIOLOGICS competes with TYSON FOODS, United Natural, UNIVERSAL MUSIC, SENECA FOODS-A, and Cal-Maine Foods. WuXi Biologics Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the Peoples Republic of China, North America, Europe, and internationally. WuXi Biologics Inc. is a subsidiary of WuXi Biologics Holdings Limited. WUXI BIOLOGICS is traded on Frankfurt Stock Exchange in Germany.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US98260N1081 |
| Business Address | No 108, Meiliang |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.wuxibiologics.com |
| Currency | EUR - Euro |
You should never invest in WUXI BIOLOGICS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of WUXI Stock, because this is throwing your money away. Analyzing the key information contained in WUXI BIOLOGICS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
WUXI BIOLOGICS Key Financial Ratios
There are many critical financial ratios that WUXI BIOLOGICS's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that WUXI BIOLOGICS UNSPADR2 reports annually and quarterly.| Return On Equity | 0.12 | |||
| Return On Asset | 0.0551 | |||
| Beta | 1.11 | |||
| Z Score | 5.4 |
WUXI Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WUXI BIOLOGICS's current stock value. Our valuation model uses many indicators to compare WUXI BIOLOGICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WUXI BIOLOGICS competition to find correlations between indicators driving WUXI BIOLOGICS's intrinsic value. More Info.WUXI BIOLOGICS UNSPADR2 is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for WUXI BIOLOGICS UNSPADR2 is roughly 2.23 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WUXI BIOLOGICS's earnings, one of the primary drivers of an investment's value.WUXI BIOLOGICS UNSPADR2 Systematic Risk
WUXI BIOLOGICS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. WUXI BIOLOGICS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on WUXI BIOLOGICS UNSPADR2 correlated with the market. If Beta is less than 0 WUXI BIOLOGICS generally moves in the opposite direction as compared to the market. If WUXI BIOLOGICS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one WUXI BIOLOGICS UNSPADR2 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of WUXI BIOLOGICS is generally in the same direction as the market. If Beta > 1 WUXI BIOLOGICS moves generally in the same direction as, but more than the movement of the benchmark.
WUXI BIOLOGICS November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of WUXI BIOLOGICS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of WUXI BIOLOGICS UNSPADR2. We use our internally-developed statistical techniques to arrive at the intrinsic value of WUXI BIOLOGICS UNSPADR2 based on widely used predictive technical indicators. In general, we focus on analyzing WUXI Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build WUXI BIOLOGICS's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.5 | |||
| Information Ratio | 0.1183 | |||
| Maximum Drawdown | 28.36 | |||
| Value At Risk | (5.35) | |||
| Potential Upside | 11.85 |
Complementary Tools for WUXI Stock analysis
When running WUXI BIOLOGICS's price analysis, check to measure WUXI BIOLOGICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WUXI BIOLOGICS is operating at the current time. Most of WUXI BIOLOGICS's value examination focuses on studying past and present price action to predict the probability of WUXI BIOLOGICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WUXI BIOLOGICS's price. Additionally, you may evaluate how the addition of WUXI BIOLOGICS to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |